Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513485 · ClinicalTrials.gov registry record · Phase 4
Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
NCT02513485 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 57 participants.
The verdict
NCT02513485, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the changes that happen in the brain and the body when a person is depressed. This study will determine if the level of inflammation in the body is related to symptoms of depression, how well the person thinks, and how certain brain regions communicate.
Interventions
- DRUG Placebo
- DRUG Levodopa+carbidopa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2015-10-09 |
| Est. Completion | 2020-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02513485
The ClinicalTrials.gov registry entry for NCT02513485 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02513485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02513485 about?
NCT02513485 is a clinical study titled "Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa". The purpose of this study is to learn more about the changes that happen in the brain and the body when a person is depressed. This study will determine if the level of inflammation in the body is related to symptoms of depression, how well the person thinks, and how certain brain regions communicat...
What is the current status of trial NCT02513485?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2015-10-09. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT02513485?
The interventions under investigation include: Placebo (DRUG), Levodopa+carbidopa (DRUG).
Who is sponsoring clinical trial NCT02513485?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.